Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
JW Therapeutics Announces NMPA Approval of the Supplemental Biological License Application for Carteyva® in Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma
2024-08-27 17:00
Constellar and MY Exhibition Forge Strategic Partnership to Boost Agri-Food Technology and Aquaculture in Singapore and Taiwan region
2024-08-27 14:00
Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value, and Proven Ability to Expedite Quality Clinical Programs
2024-08-27 11:30
ArkBio Presented at the 8th Annual IPF Summit and Announced Completion of Patient Enrollment for Phase 2 Clinical Trial of AK3280, a Next-Generation Drug for IPF Treatment
2024-08-27 09:00
CStone Reports 2024 Interim Results and Recent Corporate Updates
2024-08-23 22:20
Antengene Announces 2024 Interim Financial Results, Highlights Progress in R&D and Commercialization
2024-08-23 12:32
Inaugural Process Innovation Asia Pacific to Drive Industry Transformation for South-East Asia's Chemicals and Pharmaceuticals
2024-08-22 15:30
Everest Medicines Announces the Initiation of an Investigator-Initiated Clinical Trial (IIT) for Personalized mRNA Cancer Vaccine Program EVM16
2024-08-22 08:00
China's First Approved KRAS G12C Inhibitor: Innovent Announces the Approval of Dupert® (Fulzerasib) by the National Medical Products Administration of China
2024-08-22 08:00
Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption
2024-08-21 09:00
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Second NDA Accepted by NPMA, locally advanced or metastatic EGFR-mutant NSCLC
2024-08-20 16:32
Allozymes and Adisseo Partner on Next-Gen Animal Feed Production Using Rapid Microfluidics Technology
2024-08-19 15:57
Ainex Unveils Advanced Endoscopy AI System at GIHEP & Singapore Hepatology Conference 2024
2024-08-19 08:01
Alphamab Oncology Reports 2024 Interim Results and Business Highlights
2024-08-16 11:18
Cresilon Receives FDA Clearance for TRAUMAGEL
2024-08-15 20:45
NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT
2024-08-15 13:43
NSG BioLabs and Merck Collaborates to Support Biotech Start-ups to Advance Research & Innovations
2024-08-15 10:00
Australian biotech incubator Proto Axiom announces $20M Series B first close
2024-08-13 10:21
Registrational Phase III Study of Lisaftoclax in Newly-Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome Cleared by China CDE
2024-08-13 09:52
Pantai Hospital Kuala Lumpur Introduces Outpatient Parenteral Antimicrobial Therapy (OPAT) for Improved Patient Care
2024-08-13 08:53
1
11
12
13
14
15
234